{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:13:17Z","timestamp":1761167597124,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.ghir.2006.03.003","type":"journal-article","created":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T13:42:54Z","timestamp":1145454174000},"page":"79-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"S","title":["Renal osteodystrophy in children: A systemic disease associated with cardiovascular manifestations"],"prefix":"10.1016","volume":"16","author":[{"given":"Craig B.","family":"Langman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen R.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2006.03.003_bib1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1053\/j.ajkd.2003.12.003","article-title":"Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy","volume":"43","author":"Martin","year":"2004","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.ghir.2006.03.003_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00467-005-2082-7","article-title":"Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines","volume":"21","author":"Klaus","year":"2006","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ghir.2006.03.003_bib3","doi-asserted-by":"crossref","unstructured":"K\/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease, Am. J. Kidney Dis. 46 (Suppl. 1) (2005) 1\u2013121.","DOI":"10.1053\/j.ajkd.2005.07.028"},{"key":"10.1016\/j.ghir.2006.03.003_bib4","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ghir.2006.03.003_bib5","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1542\/peds.111.6.1416","article-title":"National Kidney Foundation\u2019s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification","volume":"111","author":"Hogg","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ghir.2006.03.003_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.2003.50007","article-title":"Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey","volume":"41","author":"Coresh","year":"2003","journal-title":"Am. J. Kidney Dis."},{"issue":"5 Suppl. 3","key":"10.1016\/j.ghir.2006.03.003_bib7","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ghir.2006.03.003_bib8","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2006.03.003_bib9","unstructured":"US Renal Data System, USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2005."},{"key":"10.1016\/j.ghir.2006.03.003_bib10","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2006.03.003_bib11","doi-asserted-by":"crossref","unstructured":"M.F. Holick, Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease, Am. J. Clin. Nutr. 80 (Suppl. 6) (2004) 1678S\u20131688S.","DOI":"10.1093\/ajcn\/80.6.1678S"},{"key":"10.1016\/j.ghir.2006.03.003_bib12","unstructured":"US Department of Health and Human Services. Bone Health and Osteoporosis: A Report of the Surgeon General. US Department of Health and Human Services, Office of the Surgeon General, Rockville, MD, 2004, p. 257."},{"key":"10.1016\/j.ghir.2006.03.003_bib13","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jada.2004.03.028","article-title":"Vitamin D intake in the United States","volume":"104","author":"Moore","year":"2004","journal-title":"J. Am. Diet. Assoc."},{"key":"10.1016\/j.ghir.2006.03.003_bib14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1523-1755.2003.00114.x","article-title":"Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats","volume":"64","author":"Takemoto","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.ghir.2006.03.003_bib15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0272-6386(97)90330-9","article-title":"The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure","volume":"29","author":"Martinez","year":"1997","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ghir.2006.03.003_bib16","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/j.1523-1755.2005.00651.x","article-title":"Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?","volume":"68","author":"Levin","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ghir.2006.03.003_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jsbmb.2004.03.004","article-title":"Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure","volume":"89\u201390","author":"Li","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ghir.2006.03.003_bib18","doi-asserted-by":"crossref","first-page":"2739S","DOI":"10.1093\/jn\/135.11.2739S","article-title":"The vitamin D epidemic and its health consequences","volume":"135","author":"Holick","year":"2005","journal-title":"J. Nutr."},{"key":"10.1016\/j.ghir.2006.03.003_bib19","first-page":"2739","article-title":"Calcium metabolism in essential hypertension: relationship to altered renin system activity","volume":"45","author":"Resnick","year":"1986","journal-title":"Fed. Proc."},{"key":"10.1016\/j.ghir.2006.03.003_bib20","doi-asserted-by":"crossref","first-page":"c21","DOI":"10.1159\/000088295","article-title":"Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis","volume":"102","author":"Kim","year":"2005","journal-title":"Nephron Clin. Pract."},{"key":"10.1016\/j.ghir.2006.03.003_bib21","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1046\/j.1523-1755.64.s87.19.x","article-title":"An update on vitamin D as related to nephrology practice: 2003","volume":"87","author":"Coburn","year":"2003","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.ghir.2006.03.003_bib22","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism","volume":"68","author":"Cunningham","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ghir.2006.03.003_bib23","doi-asserted-by":"crossref","unstructured":"J.R. Wu-Wong, M. Nakane, J. Ma, X. Ruan, P.E. Kroeger, Effects of vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells, Atherosclerosis (2005) August 8 (Epub ahead of print).","DOI":"10.1016\/j.atherosclerosis.2005.06.046"},{"key":"10.1016\/j.ghir.2006.03.003_bib24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int."},{"issue":"Suppl. A","key":"10.1016\/j.ghir.2006.03.003_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ghir.2005.06.009","article-title":"Renal osteodystrophy: a pediatric perspective, 2005","volume":"15","author":"Langman","year":"2005","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2006.03.003_bib26","first-page":"1","article-title":"Growth hormone and the cardiovascular function","volume":"30","author":"Svensson","year":"2005","journal-title":"Minerva Endocrinol."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637406000281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637406000281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:42:44Z","timestamp":1761086564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637406000281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":26,"alternative-id":["S1096637406000281"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2006.03.003","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal osteodystrophy in children: A systemic disease associated with cardiovascular manifestations","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2006.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}